Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer

C Moynihan, E K Bancroft, A Mitra, A Ardern-Jones, E Castro, E C Page, R A Eeles, C Moynihan, E K Bancroft, A Mitra, A Ardern-Jones, E Castro, E C Page, R A Eeles

Abstract

Objective: Increased risk of prostate cancer (PCa) is observed in men with BRCA1/BRCA2 mutations. Sex and gender are key determinants of health and disease although unequal care exists between the sexes. Stereotypical male attitudes are shown to lead to poor health outcomes.

Methods: Men with BRCA1/2 mutations and diagnosed with PCa were identified and invited to participate in a qualitative interview study. Data were analysed using a framework approach. "Masculinity theory" was used to report the impact of having both a BRCA1/2 mutation and PCa.

Results: Eleven of 15 eligible men were interviewed. The umbrella concept of "Ambiguity in a Masculine World" was evident. Men's responses often matched those of women in a genetic context. Men's BRCA experience was described, as "on the back burner" but "a bonus" enabling familial detection and early diagnosis of PCa. Embodiment of PCa took precedence as men revealed stereotypical "ideal" masculine responses such as stoicism and control while creating new "masculinities" when faced with the vicissitudes of having 2 gendered conditions.

Conclusion: Health workers are urged to take a reflexive approach, void of masculine ideals, a belief in which obfuscates men's experience. Research is required regarding men's support needs in the name of equality of care.

Keywords: BRCA1; BRCA2; gender/masculinity; prostate cancer; psychosocial.

© 2017 The Authors. Psycho-Oncology published by John Wiley & Sons Ltd.

References

    1. Edwards SM, Kote‐Jarai Z, Meitz J, et al. Two percent of men with early‐onset prostate cancer harbour germline mutations in the BRCA2 gene. Am J Hum Genet. 2003;72(1):1‐12.
    1. Castro E, Goh C, Olmos D, et al. Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. J Clin Oncol. 2013;31:1748‐1757.
    1. Leongamornlert D, Mahmud N, Tymrakiewicz M, et al. Germline BRCA1 mutations increase prostate cancer risk. Br J Cancer. 2012;106:1697‐1701.
    1. Kote‐Jarai Z, Leongamornlert D, Saunders E, et al. BRCA2 is a moderate penetrance gene contributing to young‐onset prostate cancer: implications for genetic testing in prostate cancer patients. Br J Cancer. 2011;105:1230‐1234.
    1. Moynihan C. Men, women, sex and gender. Eur J Cancer Care (Engl). 2002;3:166‐172.
    1. Pettingale K, Morris T, Greer S, Haybittle J. Mental attitudes to cancer: an additional prognostic factor. The Lancet. 1985;325(1):750‐754.
    1. Hewitt M, Hardman R, Holland J. (Eds). Meeting Psychosocial Needs of Women with Breast Cancer. Institute of Medicine (US and National Research Council (US) National Cancer Policy Board). Washington (DC): National Academies Press (US); 2004.
    1. Moynihan C. Theories in health care and research. Theories of masculinity. Br Med J. 1998;317:1072‐1075.
    1. Courtenay W. Constructions of masculinity and their influence on men's well‐being: a theory of gender and health. Soc Sci Med. 2000;50:1385‐1401.
    1. Wenger L, Oliffe J. Men managing cancer. Sociology of Health and Illness. 2014;36(1):108‐122.
    1. Doyal L. Gender equity in health: debates and dilemmas In: Bendelow G, Carpenter M, Vautier C, Williams S, eds. Gender, Health and Healing: the Public Private Divide. London: Routledge; 2002.
    1. d'Agincourt‐Canning L, Baird P. Genetic testing for hereditary cancers. The impact of gender on interest, uptake and ethical considerations. Clinical Reviews in Oncology/Hematology. 2006;58:114‐123.
    1. Chambers S, Chung E, Wittert G, Hyde M. Erectile dysfunction, masculinity and psychosocial outcomes: a review of the literature of men after prostate cancer treatment. Trails Androl Urol. 2017;6(1):60‐68.
    1. Oliffe J. Constructions of masculinity following prostatectomy induced impotence. Soc Sci Med. 2005;6010:2249‐2259.
    1. Oliffe J. Embodied masculinity and androgen deprivation therapy. Sociology of Health and Illness. 2006;28(4):410‐432.
    1. Wall D, Kristjanson L. Men culture and hegemonic masculinity: understanding the experience of prostate cancer. Nursing Enquiry. 2005;12(2):87‐97.
    1. Stromsvik N, Raheim M, Oyen N, Gjengedal E. Men in the women's world of hereditary breast and ovarian cancer—a systematic review. Familiar Cancer. 2009;8(3):221‐229.
    1. Daly M. The Impact of social roles on the experience of men in BRCA1/2 families: implications for counseling. J Genetic Counselling. 2009;18:42‐48.
    1. d'Agincourt Canning L. Experiences of genetic risk: disclosure and the gendering of responsibility. Bioethics. 2001;15(3):231‐147.
    1. Quincey K, Williamson I, Winstanley S. Marginalised malignancies: a qualitative synthesis of men's accounts of living with breast cancer. Soc Sci Med. 2016;149:17‐25.
    1. Iredale K, Brain B, Williams E, France E, Gray J. The experience of men with breast cancer in the United Kingdom. Eur J Cancer. 2006;42(3):334‐341.
    1. Hallowell N, Arden‐Jones A, Eeles R, et al. Men's decision making about predictive BRCA1/2 testing: the role of family. J Genet Counselling. 2005;14(3):207‐217.
    1. Bancroft EK, Castro E, Ardern‐Jones A, et al. “It's all very well reading the letters in the genome, but it's a long way to being able to write”: Men's interpretations of undergoing genetic profiling to determine future risk of prostate cancer. Fam Cancer. 2015;13(4):625‐635.
    1. Foster C, Evans D, Eeles R, et al. Predictive testing for BRCA1/2: attributes, risk perception and management in a multi‐centre clinical cohort. Br J Cancer. 2002;86:1209‐1216.
    1. Daly P, Nolan C, Green A, et al. Predictive testing for BRCA1 and 2 mutations: a male contribution. Ann Oncol. 2003;14:549‐553.
    1. Connell R. Masculinities. Berkeley: University of California Press; 1995.
    1. Kimmel M. Masculinity as homophobia: fear, shame and silence in the construction of gender identity In: Brod H, Kaufman M, eds. Theorising Masculinities. London: Sage; 1994:119‐141.
    1. Bottorff J, Oliffe J, Robinson C, Carey J. Gender relations and health research: a review of current practices. International Journal for Equity in Health. 2011;10(60):1‐8.
    1. Charmaz K. Identity, dilemmas of chronically ill men In: Sabo D, Gordon D, eds. Men's Health and Illness: Gender, Power and the Body. Thousand Oaks, CA: Sage; 1995.
    1. Hallowell N, Arden‐Jones A, Eeles R, et al. Communication about genetic testing in families of male BRCA1/2 carriers and non‐carriers: patterns, priorities and problems. Clin Genet. 2005;67:492‐502.
    1. Arden HN, Jones A, Eeles R, et al. Guilt, blame and responsibility: men's understanding of their role in the transmission of BRCA1/2 mutations within their family. Sociology of Health and Illness. 2006;28(7):969‐988.
    1. Hallowell N. Doing the right thing: genetic risk and responsibility. Sociology of Health and illness. 1999;21(5):597‐621.
    1. Barbour R. Introducing Qualitative Research: A Student's Guide to the Craft of Doing Qualitative Research. London, UK: Sage Publications; 2008.
    1. Pope C, Ziebland S, Mays N. Analysing qualitative data. British Medial Journal. 2000;320:124‐126.
    1. Oliffe J, Thorne S. Men, masculinities and prostate cancer: Australian and Canadian patient perspectives of communication with male physicians. Qual Health Res. 2007;17(2):149‐161.
    1. Bowlby J. The Making and Breaking of Affectional Bonds. London: Tavistock; 1979.
    1. Gray RE, Fitch M, Phillips C, Labrecque M, Fergus K. To tell or not to tell: patterns of disclosure among men with prostate cancer. Psychooncology. 2000;9:273‐282.
    1. Cormie P, Oliffe J, Galvao D, Newton R, Chambers S. Improving psychosocial health in men with prostate cancer through an intervention that reinforces masculine values ‐ exercise. Psychooncology. 2016;25(2):232‐235.
    1. Wenger LM, Oliffe J, Bottorff JL. Psychosocial oncology supports for men: a scoping review and recommendations. Am J Mens Health. 2016;10(1):39‐58.
    1. Connell R, Messerschmidt J. Hegemonic masculinity: rethinking the concept. Gender Society. 2005;19:829‐859.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere